These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 94702)

  • 1. HLA antigens in a psoriatic family: comparative studies with MLC, HTC, PLT and serological HLA-DR determinations.
    Marcusson J; Möller E
    Tissue Antigens; 1979 Oct; 14(4):279-95. PubMed ID: 94702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further studies on psoriasis-associated HLA-Dw/DR7 using PLT cells primed against a familial psoriasis-linked HLA haplotype.
    Marcusson JA; Möller E
    Tissue Antigens; 1986 Jan; 27(1):1-9. PubMed ID: 3082035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of paternal and maternal HLA-B/D recombinants in a single family.
    Hsu SH; Pollard MK; Bias WB
    Hum Immunol; 1980 Dec; 1(4):325-30. PubMed ID: 6455396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anomalous mixed lymphocyte culture reactivity between HLA--A, --B, --C, --DR identical siblings.
    Reinsmoen NL; Noreen HJ; Friend PS; Giblett ER; Greenberg LJ; Kersey JH
    Tissue Antigens; 1979 Jan; 13(1):19-34. PubMed ID: 154195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reactions of primed lymphocytes (PLT) and their genetic determination (author's transl)].
    Hajek-Rosenmayr A
    Wien Klin Wochenschr; 1982 Jan; 94(1):13-9. PubMed ID: 6177103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexity of the HLA-D region studied by primed-lymphocyte test.
    Segall M; Reinsmoen NL; Noreen HJ; Bach FH
    J Exp Med; 1980 Aug; 152(2 Pt 2):156s-163s. PubMed ID: 6157765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Split of HLA-D into two regions alpha and beta by a recombination between HLA-D and GLO. I. Study in a family and primed lymphocyte typing for determinants coded by the beta region.
    Mawas C; Charmot D; Mercier P
    Tissue Antigens; 1980 May; 15(5):458-66. PubMed ID: 6160646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LB-Q1 and LB-Q2: two determinants defined in the primed lymphocyte test and independent of HLA-D/DR, MB/LB-E, or SB.
    Termijtelen A; van den Berge SJ; van Rood JJ
    Hum Immunol; 1983 Sep; 8(1):11-5. PubMed ID: 6195131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoriasis and arthritic lesions in relation to the inheritance of HLA genotypes: a family study.
    Marcusson J; Möller E; Rosenthal L; Lindwall N; Thyresson N
    Acta Derm Venereol; 1978; 58(6):511-20. PubMed ID: 83075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivity pattern of 15 HLA-Dw1 homozygous typing cells in primary mixed lymphocyte culture.
    Schneider EM; Krupp U; Marchal S; Rittner C
    Hum Genet; 1984; 65(3):242-7. PubMed ID: 6230305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra HLA-D/DR region recombinant detected by primed lymphocyte typing (PLT).
    Jakobsen BK; Kristensen T; Lamm LU; Morling N; Bruun-Petersen G; Platz P; Ryder LP; Svejgaard A
    Tissue Antigens; 1983 Aug; 22(2):123-33. PubMed ID: 6578608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC specified lymphocyte activating and suppressor activating determinants in human mixed lymphocyte reactions.
    Fainboim L; Jaraquemada D; Festenstein H; Sachs JA
    Scand J Immunol; 1981 Dec; 14(6):655-67. PubMed ID: 6177031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further study on HLA-A, B, C, D, DR and haplotype antigen frequencies in psoriasis vulgaris.
    Tsuji K; Inouye H; Nose Y; Sasazuki T; Ozawa A; Ohkido M
    Acta Derm Venereol Suppl (Stockh); 1979; 87():107-8. PubMed ID: 93841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary MLC responses of primed lymphocytes after selective sensitization to non-HLA-D determinants.
    Wank R; Schendel DJ; Blanco ME; Dupont B
    Scand J Immunol; 1979; 9(6):499-505. PubMed ID: 88755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic evidence that HLA-DR (Ia) specificities include multiple HLA-D determinants on a single haplotype.
    Fuller TC; Einarson M; Pinto C; Ahern A; Yunis EJ
    Transplant Proc; 1978 Dec; 10(4):781-4. PubMed ID: 83710
    [No Abstract]   [Full Text] [Related]  

  • 16. Generation of discriminatory PL against HLA-D antigens not detected by serology.
    Zier KS; Gansbacher B
    Hum Immunol; 1981 Aug; 3(1):57-65. PubMed ID: 6168622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic heterogeneity of DR4 in the Old Order Amish and two new HLA-D specificities.
    Hsu SH; Pollard MK; Chan MM; Bias WB
    Hum Immunol; 1981 Mar; 2(2):165-72. PubMed ID: 6167556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Typing for MLC determinants: methods and applications.
    Thomsen M; Ryder LP; Svejgaard A
    Scand J Immunol; 1976 Jun; Suppl 5():157-74. PubMed ID: 79216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-D-DR relationships: PLT studies of HLA-D specificities associated with DR1, DR2, and DR4.
    Suciu-Foca N; Godfrey M; Khan R
    Hum Immunol; 1981 Jul; 2(4):295-304. PubMed ID: 6168618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of HLA-DR matching for nonreactivity in mixed lymphocyte culture (MLC) depends on matching for HLA-D.
    Vaidya S; Colbaugh P; Stastny P
    Transplant Proc; 1979 Dec; 11(4):1779-80. PubMed ID: 93804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.